logo

For the Inventor, By the Inventor

Daejeon, South Korea

Y-Biologics Inc.


USPTO Granted Patents = 12

Forward Citations = 8

Loading Chart...
Loading Chart...

61 inventors (with patents filed for the assignee):

goldMedal Young Woo Park (12 out of 40 patents)

silverMedal Bum-chan Park (10 out of 11 patents)

bronzeMedal Jae Eun Park (6 out of 8 patents)

4.  Seok Ho Yoo (5 out of 9 patents)

5.  Young-Gyu Cho (4 out of 6 patents)

6.  Seil Jang (4 out of 5 patents)

7.  Jung Chae Lim (4 out of 4 patents)

8.  Si Hyung Lee (3 out of 3 patents)

9.  Youngja Song (3 out of 3 patents)

10.  Gi Sun Baek (3 out of 3 patents)

11.  Hyun Mi Lee (3 out of 4 patents)

12.  Ji-Young Shin (2 out of 2 patents)

13.  Sunha Yoon (2 out of 2 patents)

14.  Yunseon Choi (2 out of 2 patents)

15.  Jisu Lee (2 out of 2 patents)


12 patents:

1. 12168060 - Antibody-drug conjugates comprising anti-B7-H3 antibodies (2024-12-17),
2. 12139530 - Bispecific antibody specifically binding to IL-17A and TNF-α (2024-11-12),
3. 11945864 - Monoclonal antibody specifically binding to LAG-3 and use thereof (2024-04-02),
4. 11306141 - Antibody against human DLK1 and use thereof (2022-04-19),
5. 11248048 - Antibody to programmed cell death 1 (PD-1) and use thereof (2022-02-15),
6. 10919966 - Antibody to programmed death-ligand 1 (PD-L1) and use thereof (2021-02-16),
7. 10836833 - Cell engaging binding molecules (2020-11-17),
8. 10654944 - Cell engaging binding molecules (2020-05-19),
9. 10640576 - Cell engaging binding molecules (2020-05-05),
10. 10633458 - Cell engaging binding molecules (2020-04-28),
11. 10448662 - Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog (2019-10-22),
12. 9631020 - Anti-c-Met antibody having HGF activity and use thereof (2017-04-25),
Company Overview
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced biological technologies to create novel treatments, particularly in the fields of immunology and oncology. Y-Biologics is committed to addressing unmet medical needs through its cutting-edge research and development efforts, aiming to improve patient outcomes and contribute to the advancement of healthcare solutions globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#53 in Daejeon

#934 in South Korea

#48,129 in the World

Daejeon, KR
Daejeon, South Korea

Y-Biologics Inc.

Forward Citations = 8

61 inventors:

goldMedal Young Woo Park (12 out of 40 patents)

silverMedal Bum-chan Park (10 out of 11 patents)

bronzeMedal Jae Eun Park (6 out of 8 patents)

4.  Seok Ho Yoo (5 out of 9 patents)

5.  Young-Gyu Cho (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Y-Biologics Inc.. Retrieved from https://idiyas.com/company/y-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…